Berman Tabacco Announces Investigation of SelectQuote, Inc. (NYSE:SLQT) — Neutral
SLQT GlobeNewsWire — December 02, 2025BOSTON, Dec. 02, 2025 (GLOBE NEWSWIRE) -- Berman Tabacco, a national law firm representing investors, announces its investigation into potential stockholder claims involving SelectQuote, Inc. (“SelectQuote”) (NYSE:SLQT) allegedly receiving illegal payments from health insurance providers.
MLTX FINAL DEADLINE: ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages MoonLake Immunotherapeutics Investors to Secure Counsel Before Important December 15 Deadline in Securities Class Action – MLTX — Neutral
MLTX GlobeNewsWire — December 02, 2025NEW YORK, Dec. 02, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of MoonLake Immunotherapeutics (NASDAQ: MLTX) between March 10, 2024 and September 29, 2025, both dates inclusive (the “Class Period”), of the important December 15, 2025 lead plaintiff deadline.
Nutex Health Inc. (NUTX) Discusses Restated 2024 Results and Combined Second and Third Quarter 2025 Financial Performance Transcript — Neutral
NUTX Seeking Alpha — December 02, 2025Nutex Health Inc. (NUTX) Discusses Restated 2024 Results and Combined Second and Third Quarter 2025 Financial Performance Transcript
Third Coast Bancshares Is Undervalued And Worth Banking On — Positive
TCBX Seeking Alpha — December 02, 2025Third Coast Bancshares remains a "Buy," supported by strong asset quality, attractive valuation, and robust balance sheet growth. TCBX's net interest margin rose to 4.05%, driving net profits up to $44.8 million and returns well above industry minimums. The announced $123 million Keystone Bancshares merger expands Texas presence, especially in Austin, with potential cost synergies and scale benefits.
Getting engaged? There's a rising chance your ring will have a lab-grown diamond. — Neutral
SIG Market Watch — December 02, 2025Signet Jewelers said lab-grown diamonds made up 40% of its bridal business, up from a mid-30s percentage six months ago.
Taseko Mines Limited (TKO:CA) Presents at Bank of America Leveraged Finance Conference Transcript — Neutral
TGB Seeking Alpha — December 02, 2025Taseko Mines Limited (TKO:CA) Presents at Bank of America Leveraged Finance Conference Transcript
Global Payments Inc. (GPN) Presents at UBS Global Technology and AI Conference 2025 Transcript — Neutral
GPN Seeking Alpha — December 02, 2025Global Payments Inc. (GPN) Presents at UBS Global Technology and AI Conference 2025 Transcript
The Clorox Company (CLX) Presents at Morgan Stanley Global Consumer & Retail Conference 2025 Transcript — Neutral
CLX Seeking Alpha — December 02, 2025The Clorox Company (CLX) Presents at Morgan Stanley Global Consumer & Retail Conference 2025 Transcript
The Coca-Cola Company (KO) Presents at Morgan Stanley Global Consumer & Retail Conference 2025 Transcript — Neutral
COLA KO Seeking Alpha — December 02, 2025The Coca-Cola Company (KO) Presents at Morgan Stanley Global Consumer & Retail Conference 2025 Transcript
Biogen Inc. (BIIB) Presents at Evercore 8th Annual Healthcare Conference Transcript — Neutral
BIIB Seeking Alpha — December 02, 2025Biogen Inc. (BIIB) Presents at Evercore 8th Annual Healthcare Conference Transcript
Halozyme Therapeutics, Inc. (HALO) Presents at Evercore 8th Annual Healthcare Conference Transcript — Neutral
HALO Seeking Alpha — December 02, 2025Halozyme Therapeutics, Inc. (HALO) Presents at Evercore 8th Annual Healthcare Conference Transcript
Credo Technologies Posted a Blowout Quarter—Here's What's Next — Positive
CRDO MarketBeat — December 02, 2025Credo Technologies' NASDAQ: CRDO fiscal year 2026 (FY2026) Q2 results are yet another example of why the AI trade is far from over. As NVIDIA NASDAQ: NVDA and Advanced Micro Devices NASDAQ: AMD continue to dominate GPU sales for AI data centers built by Microsoft NASDAQ: MSFT, Amazon NASDAQ: AMZN, and Meta Platforms NASDAQ: META, the demand for high-speed connectivity grows in parallel.
Novo Nordisk justifies reasoning behind failed GLP-1 Alzheimer's trials — Negative
NVO Reuters — December 02, 2025Novo Nordisk in 2020 launched pivotal trials of its GLP-1 drug semaglutide in Alzheimer's patients based on studies in humans, animals and real-world findings, a top company executive said on Tuesday, acknowledging criticism that Novo's studies had design flaws.
Microsoft CEO Says AI Sector Needs Multiple Winners: 'Otherwise It'll Be A Road To Nowhere' — Neutral
MSFT Benzinga — December 02, 2025Microsoft Corporation (NASDAQ: MSFT) is among the companies that are investing heavily in data centers for AI growth. The company's CEO has a warning for the increased energy needed for the AI sector and for fears of an AI bubble.
SKYE Class Action Reminder: Skye Bioscience, Inc. Stockholders Should Contact Robbins LLP for Information About the Securities Class Action Lawsuit — Neutral
SKYE PRNewsWire — December 02, 2025SAN DIEGO , Dec. 2, 2025 /PRNewswire/ -- Company: Skye Bioscience, Inc. (NYSE: SKYE) is a clinical stage biopharmaceutical company that focuses on developing molecules that modulate G protein-coupled receptors ("GPCRs") to treat obesity, overweight, and metabolic diseases. The Company's lead product candidate is nimacimab.
Aramark: Near-Term Growth Outlook Remains Uncertain — Negative
ARMK Seeking Alpha — December 02, 2025Aramark remains a Hold as the near-term FY26 outlook is unattractive despite strong commercial momentum and major contract wins. Q4 2025 revenue growth was inflated by a 53rd week, and underlying organic growth and profitability missed expectations, with adj. EBIT margin disappointing. ARMK's record new business wins, especially in healthcare, validate its competitiveness, but onboarding and timing risks threaten revenue recognition and earnings flow-through.
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Primo Brands Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - PRMB, PRMW — Neutral
PRMB PRMW Newsfile Corp — December 02, 2025New York, New York--(Newsfile Corp. - December 2, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Primo Water Corporation (NYSE: PRMW) between June 17, 2024 and November 8, 2024, both dates inclusive, and/or (ii) purchasers of common stock of Primo Brands Corporation (NYSE: PRMB) between November 11, 2024 and November 6, 2025 (the "Class Period"), of the important January 12, 2026 lead plaintiff deadline. SO WHAT: If you purchased Primo Brands securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees …
PRMB Class Action Reminder: Primo Brands Corporation Stockholders Should Contact Robbins LLP for Information About the Securities Class Action Lawsuit — Neutral
PRMB PRNewsWire — December 02, 2025SAN DIEGO , Dec. 2, 2025 /PRNewswire/ -- Company: Primo Brands Corporation (NYSE: PRMB) purports to be a leading North American branded beverage company focused on healthy hydration, offering responsibly sourced products across multiple formats, channels, and price points, and for a wide range of consumer occasions. Its products are distributed in every U.S. state and in Canada.
Zscaler, Inc. (ZS) Presents at UBS Global Technology and AI Conference 2025 Transcript — Neutral
ZS Seeking Alpha — December 02, 2025Zscaler, Inc. ( ZS ) UBS Global Technology and AI Conference 2025 December 2, 2025 12:15 PM EST Company Participants Jagtar Chaudhry - Co-Founder, CEO & Chairman of the Board Conference Call Participants Roger Boyd - UBS Investment Bank, Research Division Presentation Roger Boyd UBS Investment Bank, Research Division All right. We will get going here.
Cencora, Inc. (COR) Presents at Citi Annual Global Healthcare Conference 2025 Transcript — Neutral
COR Seeking Alpha — December 02, 2025Cencora, Inc. (COR) Presents at Citi Annual Global Healthcare Conference 2025 Transcript